What is the current annual EBITDA of TAK?

As of today, TAK annual EBITDA is $8.37B

What is 1-year change in TAK annual EBITDA?

TAK annual EBITDA is down -8.11% year-over-year

What is 3-year change in TAK annual EBITDA?

TAK annual EBITDA is down -14.23% over the past 3 years

How far is TAK annual EBITDA from its all-time high?

TAK annual EBITDA is currently -21.19% below its historical high of $10.62B set on March 31, 2022

How does TAK annual EBITDA rank versus sector peers?

TAK annual EBITDA is higher than 98.31% of companies in Healthcare sector

When is TAK next annual earnings release?

As of today, the next annual earnings release for TAK has not been scheduled

What is the current quarterly EBITDA of TAK?

As of today, TAK quarterly EBITDA is $2.57B

What is TAK quarterly EBITDA most recent change?

TAK quarterly EBITDA was down -0.55% on September 30, 2026

What is 1-year change in TAK quarterly EBITDA?

TAK quarterly EBITDA is up +19.15% year-over-year

How far is TAK quarterly EBITDA from its all-time high?

TAK quarterly EBITDA is currently -30.84% below its historical high of $3.71B set on June 30, 2021

How does TAK quarterly EBITDA rank versus sector peers?

TAK quarterly EBITDA is higher than 98.09% of companies in Healthcare sector

When is TAK next earnings release?

The next earnings release for TAK is on January 28, 2027

What is the current TTM EBITDA of TAK?

As of today, TAK TTM EBITDA is $9.68B

What is TAK TTM EBITDA most recent change?

TAK TTM EBITDA was up +4.45% on September 30, 2026

What is 1-year change in TAK TTM EBITDA?

TAK TTM EBITDA is up +15.28% year-over-year

How far is TAK TTM EBITDA from its all-time high?

TAK TTM EBITDA is currently -9.00% below its historical high of $10.64B set on September 30, 2021

How does TAK TTM EBITDA rank versus sector peers?

TAK TTM EBITDA is higher than 98.09% of companies in Healthcare sector

When is TAK next earnings release?

The next earnings release for TAK is on January 28, 2027

TAK EBITDA History & Chart Since 1991

Annual EBITDA

$8.37B$738.88M-8.11%

March 31, 2026

Summary

Current Value: As of today, TAK annual EBITDA is $8.37B, down -8.11% on March 31, 2026
Historical Performance: TAK annual EBITDA is down -14.23% over the past 3 years, down -11.85% over the past 5 years
All-Time High Comparison: TAK annual EBITDA is currently -21.19% below its historical high of $10.62B set on March 31, 2022
3-Year Low Comparison: TAK annual EBITDA is at its 3-year low
Sector Comparison: TAK annual EBITDA is higher than 98.31% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

TAK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Mar 31, 26	$8.37B	-8.1%	-14.2%	-11.8%	+51.3%
Quarterly EBITDA	Sep 30, 26	$2.57B	+19.1%	+41.3%	+8.0%	+61.8%
TTM EBITDA	Sep 30, 26	$9.68B	+15.3%	+7.2%	-9.0%	+66.6%
Price	Nov 6, 26	$21.02	+54.1%	+53.3%	+47.5%	-6.2%
PE Ratio	Nov 6, 26	341.79	+97.2%	+1003.6%	+3264.1%	+2765.0%
Annual Revenue	Mar 31, 26	$29.90B	-0.5%	+0.6%	-0.8%	+80.4%
Annual EPS	Mar 31, 26	-$0.32	-245.6%	-143.1%	-128.5%	-117.5%
	Mar 31, 26	$3.59B	-12.9%	-26.2%	-15.0%	-16.3%
Annual Net Income	Mar 31, 26	-$1.01B	-242.3%	-143.2%	-128.5%	-134.6%

EBITDA Highs

TAK Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$9.76B	N/A	-14.2%
5Y	$10.62B	Mar 31, 22	-21.2%
All	$10.62B	Mar 31, 22	-21.2%

EBITDA Lows

TAK Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$8.37B	Mar 31, 26	at low
5Y	$8.37B	Mar 31, 26	at low
All	$572.38M	Mar 1, 93	+1362.6%

EBITDA History

Year	Value	Change
2026	$8.37B	-8.1%
2025	$9.11B	+4.7%
2024	$8.70B	-10.9%
2023	$9.76B	-8.1%
2022	$10.62B	+11.8%
2021	$9.50B	+16.5%
2020	$8.15B	+93.8%
2019	$4.21B	+23.5%
2018	$3.41B	+42.7%
2017	$2.39B	-18.9%
2016	$2.94B	-16.6%
2015	$3.53B	+6.1%
2014	$3.32B	+10.1%
2013	$3.02B	-42.6%
2012	$5.26B	-5.0%
2011	$5.53B	-4.0%
2010	$5.76B	+36.5%
2009	$4.22B	+6.1%

Year	Value	Change
2008	$3.98B	-4.5%
2007	$4.17B	+9.3%
2006	$3.81B	-1.6%
2005	$3.87B	+9.5%
2004	$3.54B	+26.6%
2003	$2.79B	+12.8%
2002	$2.48B	+5.5%
2001	$2.35B	+27.7%
2000	$1.84B	+33.6%
1999	$1.38B	+16.1%
1998	$1.19B	-15.7%
1997	$1.41B	-7.1%
1996	$1.51B	+19.1%
1995	$1.27B	+71.1%
1994	$743.36M	+29.9%
1993	$572.38M	-19.4%
1992	$709.98M	+22.1%
1991	$581.40M	-

FAQ

What is the current annual EBITDA of TAK?: As of today, TAK annual EBITDA is $8.37B
What is 1-year change in TAK annual EBITDA?: TAK annual EBITDA is down -8.11% year-over-year
What is 3-year change in TAK annual EBITDA?: TAK annual EBITDA is down -14.23% over the past 3 years
How far is TAK annual EBITDA from its all-time high?: TAK annual EBITDA is currently -21.19% below its historical high of $10.62B set on March 31, 2022
How does TAK annual EBITDA rank versus sector peers?: TAK annual EBITDA is higher than 98.31% of companies in Healthcare sector
When is TAK next annual earnings release?: As of today, the next annual earnings release for TAK has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$2.57B$14.21M-0.55%

September 30, 2026

Summary

Current Value: As of today, TAK quarterly EBITDA is $2.57B, down -0.55% on September 30, 2026
Historical Performance: TAK quarterly EBITDA is up +19.15% year-over-year, up +41.34% over the past 3 years
All-Time High Comparison: TAK quarterly EBITDA is currently -30.84% below its historical high of $3.71B set on June 30, 2021
3-Year Low Comparison: TAK quarterly EBITDA is +77.68% above its 3-year low of $1.45B reached on March 31, 2025
Sector Comparison: TAK quarterly EBITDA is higher than 98.09% of companies in Healthcare sector

Performance

TAK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$2.57B	-0.6%	+19.1%	+41.3%	+8.0%
Annual EBITDA	Mar 31, 26	$8.37B	–	-8.1%	-14.2%	-11.8%
TTM EBITDA	Sep 30, 26	$9.68B	+4.5%	+15.3%	+7.2%	-9.0%
Price	Nov 6, 26	$21.02	+23.5%	+54.1%	+53.3%	+47.5%
PE Ratio	Nov 6, 26	341.79	–	+97.2%	+1003.6%	+3264.1%
Quarterly Revenue	Sep 30, 26	$7.45B	-2.6%	-1.2%	+3.3%	-2.9%
Quarterly EPS	Sep 30, 26	$0.37	+68.8%	+1576.7%	+452.1%	+182.8%
	Sep 30, 26	$1.54B	-1.5%	+101.1%	+892.2%	+39.5%
Quarterly Net Income	Sep 30, 26	$1.21B	+70.0%	+1619.0%	+464.2%	+189.3%

Quarterly EBITDA Highs

TAK Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.58B	Jun 30, 26	-0.6%
3Y	$2.64B	Jun 30, 24	-2.9%
5Y	$2.68B	Jun 30, 23	-4.2%
All	$3.71B	Jun 30, 21	-30.8%

Quarterly EBITDA Lows

TAK Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.06B	Mar 31, 26	+24.9%
3Y	$1.45B	Mar 31, 25	+77.7%
5Y	$1.45B	Mar 31, 25	+77.7%
All	-$1.91B	Mar 31, 15	+234.4%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$2.57B	-0.6%
Jun 2026	$2.58B	+25.6%
Mar 2026	$2.06B	-16.9%
Dec 2025	$2.47B	+14.8%
Sep 2025	$2.15B	-16.3%
Jun 2025	$2.57B	+78.2%
Mar 2025	$1.45B	-34.9%
Dec 2024	$2.22B	-14.5%
Sep 2024	$2.60B	-1.7%
Jun 2024	$2.64B	+63.4%
Mar 2024	$1.62B	-27.2%
Dec 2023	$2.22B	+22.4%
Sep 2023	$1.82B	-32.2%
Jun 2023	$2.68B	+37.1%
Mar 2023	$1.95B	-24.0%
Dec 2022	$2.57B	+11.4%
Sep 2022	$2.31B	-9.6%
Jun 2022	$2.55B	+47.9%
Mar 2022	$1.73B	-32.2%
Dec 2021	$2.55B	+7.1%
Sep 2021	$2.38B	-35.9%
Jun 2021	$3.71B	+102.8%
Mar 2021	$1.83B	-32.6%
Dec 2020	$2.71B	+20.1%
Sep 2020	$2.26B	-16.7%
Jun 2020	$2.71B	+37.9%
Mar 2020	$1.97B	+7.3%
Dec 2019	$1.84B	-19.0%
Sep 2019	$2.27B	+8.4%
Jun 2019	$2.09B	+296.0%
Mar 2019	$528.10M	-56.5%
Dec 2018	$1.21B	+31.1%
Sep 2018	$925.04M	-23.1%
Jun 2018	$1.20B	+195.4%
Mar 2018	$407.46M	-59.5%
Dec 2017	$1.01B	+18.4%
Sep 2017	$849.81M	-20.9%

Month	Value	Change
Jun 2017	$1.07B	+255.2%
Mar 2017	$302.29M	-70.4%
Dec 2016	$1.02B	+51.2%
Sep 2016	$676.65M	-21.0%
Jun 2016	$856.17M	+191.7%
Mar 2016	$293.54M	-67.6%
Dec 2015	$904.99M	+4.6%
Sep 2015	$865.52M	+7.2%
Jun 2015	$807.67M	+142.3%
Mar 2015	-$1.91B	-289.8%
Dec 2014	$1.01B	+18.4%
Sep 2014	$850.03M	-0.6%
Jun 2014	$854.98M	-31.5%
Dec 2013	$1.25B	+15.4%
Sep 2013	$1.08B	+5.7%
Jun 2013	$1.02B	+249.8%
Mar 2013	$292.55M	-74.1%
Dec 2012	$1.13B	-7.2%
Sep 2012	$1.22B	-11.0%
Jun 2012	$1.37B	+135.0%
Mar 2012	$581.52M	-55.7%
Dec 2011	$1.31B	-17.3%
Sep 2011	$1.59B	-10.3%
Jun 2011	$1.77B	+123.6%
Mar 2011	$791.44M	-52.4%
Dec 2010	$1.66B	+0.8%
Sep 2010	$1.65B	+12.9%
Jun 2010	$1.46B	+46.0%
Mar 2010	$1.00B	-36.6%
Dec 2009	$1.58B	+0.7%
Sep 2009	$1.57B	-2.2%
Jun 2009	$1.60B	+53.9%
Mar 2009	$1.04B	-46.1%
Dec 2008	$1.93B	+42.9%
Sep 2008	$1.35B	+3,585.3%
Jun 2008	-$38.80M	-

FAQ

What is the current quarterly EBITDA of TAK?: As of today, TAK quarterly EBITDA is $2.57B
What is TAK quarterly EBITDA most recent change?: TAK quarterly EBITDA was down -0.55% on September 30, 2026
What is 1-year change in TAK quarterly EBITDA?: TAK quarterly EBITDA is up +19.15% year-over-year
How far is TAK quarterly EBITDA from its all-time high?: TAK quarterly EBITDA is currently -30.84% below its historical high of $3.71B set on June 30, 2021
How does TAK quarterly EBITDA rank versus sector peers?: TAK quarterly EBITDA is higher than 98.09% of companies in Healthcare sector
When is TAK next earnings release?: The next earnings release for TAK is on January 28, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$9.68B$412.67M+4.45%

September 30, 2026

Summary

Current Value: As of today, TAK TTM EBITDA is $9.68B, up +4.45% on September 30, 2026
Historical Performance: TAK TTM EBITDA is up +15.28% year-over-year, up +7.24% over the past 3 years
All-Time High Comparison: TAK TTM EBITDA is currently -9.00% below its historical high of $10.64B set on September 30, 2021
3-Year Low Comparison: TAK TTM EBITDA is +16.60% above its 3-year low of $8.30B reached on June 30, 2024
Sector Comparison: TAK TTM EBITDA is higher than 98.09% of companies in Healthcare sector

Performance

TAK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$9.68B	+4.5%	+15.3%	+7.2%	-9.0%
Annual EBITDA	Mar 31, 26	$8.37B	–	-8.1%	-14.2%	-11.8%
Quarterly EBITDA	Sep 30, 26	$2.57B	-0.6%	+19.1%	+41.3%	+8.0%
Price	Nov 6, 26	$21.02	+23.5%	+54.1%	+53.3%	+47.5%
PE Ratio	Nov 6, 26	341.79	–	+97.2%	+1003.6%	+3264.1%
TTM Revenue	Sep 30, 26	$29.82B	-0.3%	+0.7%	-0.2%	-5.7%
TTM EPS	Sep 30, 26	$0.06	+118.2%	-21.9%	-86.1%	-95.6%
	Sep 30, 26	$5.34B	+16.9%	+63.0%	+46.5%	-1.1%
TTM Net Income	Sep 30, 26	$244.45M	+123.4%	-6.0%	-82.5%	-94.5%

TTM EBITDA Highs

TAK TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$9.68B	Sep 30, 26	at high
3Y	$9.68B	Sep 30, 26	at high
5Y	$10.64B	N/A	-9.0%
All	$10.64B	Sep 30, 21	-9.0%

TTM EBITDA Lows

TAK TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$8.40B	N/A	+15.3%
3Y	$8.30B	Jun 30, 24	+16.6%
5Y	$8.30B	Jun 30, 24	+16.6%
All	-$38.80M	Jun 1, 08	>+9999.0%

TTM EBITDA History

Month	Value	Change
Sep 2026	$9.68B	+4.5%
Jun 2026	$9.27B	+0.1%
Mar 2026	$9.26B	+7.1%
Dec 2025	$8.65B	+3.0%
Sep 2025	$8.40B	-5.0%
Jun 2025	$8.84B	-0.8%
Mar 2025	$8.91B	-1.9%
Dec 2024	$9.08B	-0.0%
Sep 2024	$9.08B	+9.4%
Jun 2024	$8.30B	-0.4%
Mar 2024	$8.34B	-3.9%
Dec 2023	$8.68B	-3.9%
Sep 2023	$9.03B	-5.2%
Jun 2023	$9.52B	+1.4%
Mar 2023	$9.39B	+2.5%
Dec 2022	$9.16B	+0.3%
Sep 2022	$9.14B	-0.7%
Jun 2022	$9.20B	-11.2%
Mar 2022	$10.36B	-1.0%
Dec 2021	$10.47B	-1.6%
Sep 2021	$10.64B	+1.1%
Jun 2021	$10.52B	+10.5%
Mar 2021	$9.52B	-1.4%
Dec 2020	$9.66B	+10.0%
Sep 2020	$8.78B	-0.1%
Jun 2020	$8.79B	+7.6%
Mar 2020	$8.16B	+21.4%
Dec 2019	$6.72B	+10.2%
Sep 2019	$6.10B	+28.2%
Jun 2019	$4.76B	+22.9%
Mar 2019	$3.87B	+3.2%
Dec 2018	$3.75B	+5.8%
Sep 2018	$3.54B	+2.2%
Jun 2018	$3.47B	+3.9%
Mar 2018	$3.34B	+3.3%
Dec 2017	$3.23B	-0.5%
Sep 2017	$3.25B	+5.6%

Month	Value	Change
Jun 2017	$3.08B	+7.6%
Mar 2017	$2.86B	+0.3%
Dec 2016	$2.85B	+4.3%
Sep 2016	$2.73B	-6.5%
Jun 2016	$2.92B	+1.7%
Mar 2016	$2.87B	+330.1%
Dec 2015	$667.73M	-13.2%
Sep 2015	$769.06M	+2.1%
Jun 2015	$753.57M	-5.9%
Mar 2015	$800.88M	-70.5%
Dec 2014	$2.71B	-8.2%
Sep 2014	$2.95B	-7.3%
Jun 2014	$3.18B	-12.6%
Dec 2013	$3.64B	+3.4%
Sep 2013	$3.53B	-3.7%
Jun 2013	$3.66B	-8.6%
Mar 2013	$4.00B	-6.7%
Dec 2012	$4.29B	-4.1%
Sep 2012	$4.48B	-7.6%
Jun 2012	$4.85B	-7.7%
Mar 2012	$5.25B	-3.8%
Dec 2011	$5.46B	-6.0%
Sep 2011	$5.81B	-1.1%
Jun 2011	$5.87B	+5.5%
Mar 2011	$5.56B	-3.6%
Dec 2010	$5.77B	+1.5%
Sep 2010	$5.69B	+1.5%
Jun 2010	$5.61B	-2.4%
Mar 2010	$5.75B	-0.7%
Dec 2009	$5.79B	-5.8%
Sep 2009	$6.14B	+3.6%
Jun 2009	$5.93B	+38.3%
Mar 2009	$4.29B	+32.1%
Dec 2008	$3.25B	+147.1%
Sep 2008	$1.31B	+3,485.3%
Jun 2008	-$38.80M	-

FAQ

What is the current TTM EBITDA of TAK?: As of today, TAK TTM EBITDA is $9.68B
What is TAK TTM EBITDA most recent change?: TAK TTM EBITDA was up +4.45% on September 30, 2026
What is 1-year change in TAK TTM EBITDA?: TAK TTM EBITDA is up +15.28% year-over-year
How far is TAK TTM EBITDA from its all-time high?: TAK TTM EBITDA is currently -9.00% below its historical high of $10.64B set on September 30, 2021
How does TAK TTM EBITDA rank versus sector peers?: TAK TTM EBITDA is higher than 98.09% of companies in Healthcare sector
When is TAK next earnings release?: The next earnings release for TAK is on January 28, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

TAK Official Website www.takeda.com
TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak